Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1Infections 1

Interventions

liposomal amphotericin B 2Voriconazole 2Ribavirin 2Levofloxacin 2Fluconazole 2Ciprofloxacin 2Cefazolin 2telaprevir 1peginterferon alfa-2a 1lime 1human papillomavirus vaccine, L1 type 16, 18 1amphotericin B, deoxycholate drug combination 1Vancomycin 1Valacyclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Tazobactam 1Surgical Procedures, Operative 1Sulfamethoxazole 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Palivizumab 1Olive Oil 1Ofloxacin 1Nystatin 1Moxifloxacin 1Itraconazole 1Diet 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Infections × Trimethoprim × Clear all
NCT00002850 2015-11-11

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy

University of Rochester

Phase 3 Completed
212 enrolled 12 charts
Plasma cell

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡